DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Vifor Pharma

Vifor Pharma

  • Market Notice Date: 14 November 2019 Market Notice Number: 112/2019

    Market Notice Date: 14 November 2019 Market Notice Number: 112/2019

  • Remuneration

    Remuneration

  • Switzerland Fund A-CHF for Investment Professionals Only FIDELITY FUNDS MONTHLY PROFESSIONAL FACTSHEET SWITZERLAND FUND A-CHF 31 AUGUST 2021

    Switzerland Fund A-CHF for Investment Professionals Only FIDELITY FUNDS MONTHLY PROFESSIONAL FACTSHEET SWITZERLAND FUND A-CHF 31 AUGUST 2021

  • FTSE Publications

    FTSE Publications

  • Portfolio of Investments

    Portfolio of Investments

  • Global Equity Fund Description Plan 3S DCP & JRA MICROSOFT CORP

    Global Equity Fund Description Plan 3S DCP & JRA MICROSOFT CORP

  • Swiss Small and Mid-Cap Equities – Consistent Value Creation

    Swiss Small and Mid-Cap Equities – Consistent Value Creation

  • Calvert VP EAFE International Index Portfolio 1St Quarter Holdings

    Calvert VP EAFE International Index Portfolio 1St Quarter Holdings

  • Letter to Investors

    Letter to Investors

  • Unterschleißheim, 27

    Unterschleißheim, 27

  • Barry Callebaut Annual Report 2019/20

    Barry Callebaut Annual Report 2019/20

  • Remuneration Report

    Remuneration Report

  • Instrument ID ISIN Code Description Market ID Yzai CH0043238366 ARYZTA AG XDUB Notd CH0012005267 NOVARTIS AG-REG XETR O5hd CH002

    Instrument ID ISIN Code Description Market ID Yzai CH0043238366 ARYZTA AG XDUB Notd CH0012005267 NOVARTIS AG-REG XETR O5hd CH002

  • M Funds Quarterly Holdings 3.31.2021*

    M Funds Quarterly Holdings 3.31.2021*

  • Stoxx® Global 1800 Ex Usa Minimum Variance Index

    Stoxx® Global 1800 Ex Usa Minimum Variance Index

  • Switzerland's Most Attractive Employers 2017

    Switzerland's Most Attractive Employers 2017

  • Lonza Annual Report 2020.Pdf

    Lonza Annual Report 2020.Pdf

  • Instrument Changes Effective 24Th October 2017

    Instrument Changes Effective 24Th October 2017

Top View
  • Portfolio and Performance Review the Swiss Helvetia Fund, Inc
  • Capital Market Day 2018
  • Stoxx® Europe 600 Health Care Index
  • The Octavian Seminar
  • Remuneration Report
  • ANNUAL REPORT 2020 Our Mission Is to Help Patients Around the World with Severe and Chronic Diseases Lead ­Better, Healthier Lives
  • Switzerland Wake up in Brief
  • Weekly Equity Market Update
  • ANNUAL REPORT 2019 on the Cover Learn More About Christine’S Story ‘Facing Iron Deficiency’ Viforpharma.Com/Patients TABLE of CONTENTS
  • Results of Zrating Study 2020 on Corporate Governance
  • ANNUAL REPORT 2017 Annual Report 2017 at a GLANCE
  • Annual Report 2018
  • Articles & Newsletter 2019.Xlsx
  • Companies Analysed in the CDP Europe Report
  • Preliminary Agenda Best of Switzerland Conference
  • Read POSIT MTF Market Notice
  • ESG Swiss Equities Certificate
  • Vontobel Fund - Swiss Mid and Small Cap Equity I


© 2024 Docslib.org    Feedback